{"id":143,"date":"2019-02-14T12:42:10","date_gmt":"2019-02-14T16:42:10","guid":{"rendered":"http:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=143"},"modified":"2019-02-14T12:42:10","modified_gmt":"2019-02-14T16:42:10","slug":"advamed-releases-updated-code-of-ethics-effective-2020","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2019\/02\/14\/advamed-releases-updated-code-of-ethics-effective-2020\/","title":{"rendered":"AdvaMed Releases Updated Code of Ethics, Effective 2020"},"content":{"rendered":"<p>The Advanced Medical Technology Association (AdvaMed) has\u00a0<a title=\"AdvaMed press release\" href=\"https:\/\/www.advamed.org\/newsroom\/press-releases\/advamed-approves-updated-code-ethics\" target=\"_blank\" rel=\"noopener\">published<\/a>\u00a0its\u00a0<a title=\"AdvaMed Code of Ethics\" href=\"https:\/\/www.advamed.org\/sites\/default\/files\/resource\/advamed_u.s._code_of_ethics_final_-_eff._jan_1_2020.pdf\" target=\"_blank\" rel=\"noopener\">updated Code of Ethics<\/a>. The updated code will become effective on January 1, 2020. AdvaMed has also published an\u00a0<a title=\"Overview of changes to AdvaMed Code of Ethics\" href=\"https:\/\/www.advamed.org\/sites\/default\/files\/resource\/overview_-_advamed_u.s._code_of_ethics.pdf\" target=\"_blank\" rel=\"noopener\">overview of changes<\/a>.<\/p>\n<p>The updated AdvaMed Code now includes \u201cKey Concepts\u201d at the beginning of each section, with visuals, graphics, callout boxes, examples, explanations and FAQs.<\/p>\n<p>The AdvaMed Code provides medical technology companies with guidance on ethical interactions and relationships with healthcare professionals (HCPs) to ensure that medical decisions are based on the best interests of the patient.<\/p>\n<p>Because the medical technology industry is highly divergent, the AdvaMed Code drafters recognize no single compliance program fits each company. Therefore, AdvaMed encourages companies to adopt an \u201cappropriately tailored\u201d ethics and compliance program, accounting for the specific types of risks that apply to their operations. Companies adopting the AdvaMed Code are encouraged to submit to AdvaMed an annual certification stating adoption of the AdvaMed Code and implementation an effective compliance program.<\/p>\n<p><a href=\"https:\/\/www.duanemorris.com\/alerts\/advameds_updated_code_ethics_0219.html\">Read the full Duane Morris <em>Alert<\/em><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Advanced Medical Technology Association (AdvaMed) has\u00a0published\u00a0its\u00a0updated Code of Ethics. The updated code will become effective on January 1, 2020. AdvaMed has also published an\u00a0overview of changes. The updated AdvaMed Code now includes \u201cKey Concepts\u201d at the beginning of each section, with visuals, graphics, callout boxes, examples, explanations and FAQs. The AdvaMed Code provides medical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2019\/02\/14\/advamed-releases-updated-code-of-ethics-effective-2020\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AdvaMed Releases Updated Code of Ethics, Effective 2020&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[354,357,355,358,359,221,356,119],"ppma_author":[521],"class_list":["post-143","post","type-post","status-publish","format-standard","hentry","category-general","tag-advamed","tag-compliance","tag-ethics","tag-hcps","tag-jon-lourie","tag-life-sciences","tag-medical-technology","tag-rick-ball"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=143"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/143\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=143"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}